Approval · Notice of Compliance 3142 · 1998
APO-RANITIDINE: Notice of Compliance 3142
Issued October 27, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3142
- Date
- October 27, 1998
- Company
- Apotex Inc.Toronto, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Revised labelling and product monograph (rx to OTC)
- Therapeutic class
- Histamine H2-receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| APO-RANITIDINE | Not yet assigned | — |
Medicinal ingredients
- RANITIDINE HCL 75 MG per TAB